Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Actuate Therapeutics Inc (ACTU)

Actuate Therapeutics Inc (ACTU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 132,232
  • Shares Outstanding, K 19,532
  • Annual Sales, $ 0 K
  • Annual Income, $ -24,750 K
  • EBIT $ -17 M
  • EBITDA $ -17 M
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 25.69

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.63 +2.19%
on 12/20/24
10.09 -32.90%
on 12/17/24
-1.81 (-21.10%)
since 11/20/24
3-Month
5.51 +22.87%
on 09/25/24
10.09 -32.90%
on 12/17/24
-0.54 (-7.39%)
since 09/20/24

Most Recent Stories

More News
Actuate Therapeutics, Inc. Reports Positive Phase 2 Trial Results for Elraglusib in Combination with GnP for Metastatic Pancreatic Cancer

Actuate Therapeutics reports significant survival improvements in pancreatic cancer patients treated with elraglusib and GnP, with ongoing trials.Quiver AI SummaryActuate Therapeutics, Inc. announced promising...

ACTU : 6.77 (-3.97%)
Actuate Therapeutics Announces Positive Interim Phase 2 Data of Elraglusib in First Line Treatment of Metastatic Pancreatic Cancer

ACTU : 6.77 (-3.97%)
Actuate Therapeutics Announces Positive Interim Phase 2 Data of Elraglusib in First Line Treatment of Metastatic Pancreatic Cancer

ACTU : 6.77 (-3.97%)
Actuate Therapeutics to be Added to Russell 2000® Index

ACTU : 6.77 (-3.97%)
Actuate Announces FDA Rare Pediatric Disease Designation Granted to Elraglusib for Treatment of Ewing Sarcoma

ACTU : 6.77 (-3.97%)
Actuate to Participate in Lantern’s Pharma Webinar on AI-Driven Drug Development

ACTU : 6.77 (-3.97%)
Alta Copper Announces Annual General Meeting Voting Results

VANCOUVER, BC / ACCESSWIRE / June 30, 2024 / Alta Copper Corp. (TSX:ATCU)(OTCQX:ATCUF)(BVL:ATCU) ("Alta Copper" or "the Company") announces voting results for its Annual General Meeting of shareholders...

ACTU : 6.77 (-3.97%)
ATCU.TO : 0.4450 (+4.71%)
ATCUF : 0.2890 (-10.80%)

Business Summary

Actuate Therapeutics Inc. is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers. The company's lead product includes elraglusib. Actuate Therapeutics Inc. is based in FORT WORTH, Texas.

See More

Key Turning Points

3rd Resistance Point 8.54
2nd Resistance Point 8.13
1st Resistance Point 7.45
Last Price 6.77
1st Support Level 6.36
2nd Support Level 5.95
3rd Support Level 5.27

See More

52-Week High 10.16
Fibonacci 61.8% 8.38
Fibonacci 50% 7.84
Fibonacci 38.2% 7.29
Last Price 6.77
52-Week Low 5.51

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar